FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146148857> ?p ?o ?g. }

• W2146148857 endingPage "471" @default.
• W2146148857 startingPage "464" @default.
• W2146148857 abstract "To investigate the potentially protective of periconceptional folic acid use on the risk of congenital heart defects (CHDs) relative to other non-folate related malformations.We analysed data from a large regional register of birth defects (EUROCAT-Northern Netherlands), over a 10 year period (1996-2005) for a case-control study. The cases were mothers who had delivered infants with isolated or complex heart defects, without any related syndrome or genetic abnormality (n = 611). We used two control groups; one from the EUROCAT database and another from the general population. The registry controls consisted of mothers of children with a known chromosomal or genetic defect, and with infants with other non-folate related congenital malformations (n = 2401). Additional folic acid was taken as a single supplement or as a multivitamin containing folic acid in a dose of >or=400 microg daily. Mothers who had used folate antagonists or who had diabetes, and mothers of children with oral clefts, hypospadias, limb reduction- or neural tube defects, were excluded from both groups. Potentially confounding factors of periconceptional folic acid use in relation to CHD were explored, including baby's birth year, maternal body mass index, education, maternal age at delivery of index baby, smoking behaviour, and alcohol use during pregnancy. Periconceptional folic acid use revealed an odds ratio (OR) of 0.82 (95% CI 0.68-0.98) for all types of CHD relative to other malformations. The estimated relative risk for CHDs of additional folic acid use compared with the general population was comparable [OR 0.74 (95%CI 0.62-0.88)]. Subgroup analysis showed an OR of 0.62 (95% CI 0.47-0.82) for isolated septal defects. The proportions of the potential confounders between mothers of case and control infants did not differ significantly.Our results support the hypothesis that additional periconceptional folic acid use reduces CHD risk in infants. Use of periconceptional folic acid supplements was related to approximately 20% reduction in the prevalence of any CHD. Given the relatively high prevalence of CHD worldwide, our findings are important for public health." @default.
• W2146148857 created "2016-06-24" @default.
• W2146148857 creator A5005223095 @default.
• W2146148857 creator A5019985530 @default.
• W2146148857 creator A5033176504 @default.
• W2146148857 creator A5049001097 @default.
• W2146148857 creator A5087203956 @default.
• W2146148857 creator A5089298275 @default.
• W2146148857 date "2009-12-01" @default.
• W2146148857 modified "2023-10-16" @default.
• W2146148857 title "Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands" @default.
• W2146148857 cites W1963633383 @default.
• W2146148857 cites W1964800333 @default.
• W2146148857 cites W1971515320 @default.
• W2146148857 cites W1974921279 @default.
• W2146148857 cites W1981841305 @default.
• W2146148857 cites W2000491684 @default.
• W2146148857 cites W2012517517 @default.
• W2146148857 cites W2016499666 @default.
• W2146148857 cites W2019384206 @default.
• W2146148857 cites W2027931726 @default.
• W2146148857 cites W2030287768 @default.
• W2146148857 cites W2031259147 @default.
• W2146148857 cites W2057129148 @default.
• W2146148857 cites W2063215016 @default.
• W2146148857 cites W2067531986 @default.
• W2146148857 cites W2067546738 @default.
• W2146148857 cites W2076377118 @default.
• W2146148857 cites W2082382358 @default.
• W2146148857 cites W2089925335 @default.
• W2146148857 cites W2116527490 @default.
• W2146148857 cites W2119789921 @default.
• W2146148857 cites W2120684972 @default.
• W2146148857 cites W2156555817 @default.
• W2146148857 cites W2161472106 @default.
• W2146148857 cites W2162347038 @default.
• W2146148857 cites W2325417132 @default.
• W2146148857 cites W2325954328 @default.
• W2146148857 cites W4230449559 @default.
• W2146148857 cites W4237533794 @default.
• W2146148857 doi "https://doi.org/10.1093/eurheartj/ehp479" @default.
• W2146148857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19952004" @default.
• W2146148857 hasPublicationYear "2009" @default.
• W2146148857 type Work @default.
• W2146148857 sameAs 2146148857 @default.
• W2146148857 citedByCount "152" @default.
• W2146148857 countsByYear W21461488572012 @default.
• W2146148857 countsByYear W21461488572013 @default.
• W2146148857 countsByYear W21461488572014 @default.
• W2146148857 countsByYear W21461488572015 @default.
• W2146148857 countsByYear W21461488572016 @default.
• W2146148857 countsByYear W21461488572017 @default.
• W2146148857 countsByYear W21461488572018 @default.
• W2146148857 countsByYear W21461488572019 @default.
• W2146148857 countsByYear W21461488572020 @default.
• W2146148857 countsByYear W21461488572021 @default.
• W2146148857 countsByYear W21461488572022 @default.
• W2146148857 countsByYear W21461488572023 @default.
• W2146148857 crossrefType "journal-article" @default.
• W2146148857 hasAuthorship W2146148857A5005223095 @default.
• W2146148857 hasAuthorship W2146148857A5019985530 @default.
• W2146148857 hasAuthorship W2146148857A5033176504 @default.
• W2146148857 hasAuthorship W2146148857A5049001097 @default.
• W2146148857 hasAuthorship W2146148857A5087203956 @default.
• W2146148857 hasAuthorship W2146148857A5089298275 @default.
• W2146148857 hasBestOaLocation W21461488571 @default.
• W2146148857 hasConcept C112672928 @default.
• W2146148857 hasConcept C126322002 @default.
• W2146148857 hasConcept C131872663 @default.
• W2146148857 hasConcept C146304588 @default.
• W2146148857 hasConcept C156957248 @default.
• W2146148857 hasConcept C172680121 @default.
• W2146148857 hasConcept C187212893 @default.
• W2146148857 hasConcept C2776551950 @default.
• W2146148857 hasConcept C2776940978 @default.
• W2146148857 hasConcept C2777003008 @default.
• W2146148857 hasConcept C2778478650 @default.
• W2146148857 hasConcept C2779234561 @default.
• W2146148857 hasConcept C2780221984 @default.
• W2146148857 hasConcept C2908647359 @default.
• W2146148857 hasConcept C54355233 @default.
• W2146148857 hasConcept C71924100 @default.
• W2146148857 hasConcept C86803240 @default.
• W2146148857 hasConcept C99454951 @default.
• W2146148857 hasConceptScore W2146148857C112672928 @default.
• W2146148857 hasConceptScore W2146148857C126322002 @default.
• W2146148857 hasConceptScore W2146148857C131872663 @default.
• W2146148857 hasConceptScore W2146148857C146304588 @default.
• W2146148857 hasConceptScore W2146148857C156957248 @default.
• W2146148857 hasConceptScore W2146148857C172680121 @default.
• W2146148857 hasConceptScore W2146148857C187212893 @default.
• W2146148857 hasConceptScore W2146148857C2776551950 @default.
• W2146148857 hasConceptScore W2146148857C2776940978 @default.
• W2146148857 hasConceptScore W2146148857C2777003008 @default.
• W2146148857 hasConceptScore W2146148857C2778478650 @default.
• W2146148857 hasConceptScore W2146148857C2779234561 @default.
• W2146148857 hasConceptScore W2146148857C2780221984 @default.
• W2146148857 hasConceptScore W2146148857C2908647359 @default.

• next